Effect of probiotics on length of hospitalization in mild acute pancreatitis: a randomized trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042057

Enrollment

Unknown

Registered

2021-01-13

Start date

2021-02-05

Completion date

Unknown

Last updated

2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

experimental group:probiotics

control group:Placebo

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-75 years; 2.Met two of the following three diagnostic criteria for acute pancreatitis, including typical upper abdominal pain, serum amylase and/or lipase activity more than three times, and imaging manifestations of pancreatitis.

Exclusion criteria

Exclusion criteria: Patients who presented with any indication of severe acute pancreatitis were excluded from our study.

Design outcomes

Primary

Measure	Time frame
LOS;	—

Countries

China

Contacts

Public ContactYou-Dong Wan

Affiliated Hospital of Qingdao University

wanyoudong130@163.com+86 19953233457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026